Tudorza Pressair (aclidinium bromide inhalation powder)
Reviewed by: HU Medical Review Board | Last reviewed: February 2022 | Last updated: June 2023
Tudorza Pressair (aclidinium bromide inhalation powder) is a long-term maintenance treatment of bronchospasms associated with chronic obstructive pulmonary disease (COPD). It is not a rescue medicine and should not be used for treating sudden breathing problems.1
What are the ingredients in Tudorza Pressair?
The active ingredient in Tudorza Pressair is aclidinium bromide. This is a long-acting muscarinic agent (LAMA) or anticholinergic.1
How does Tudorza Pressair work?
Tudorza Pressair works by relaxing the muscles that surround the airways. For people living with COPD, the muscles lining the airways can tighten, causing the airways to become too narrow. This makes breathing difficult. This is known as a bronchospasm.1
What are the possible side effects of Tudorza Pressair?
The most common side effects include:1
- Cold symptoms
Tudorza Pressair may also cause serious side effects, including:1
- New or worsened increased pressure in the eyes (acute narrow-angle glaucoma)
- Difficulty or painful urination
- Allergic reactions, including hives, breathing problems, itching, or swelling of the face, lips, tongue, or throat
If your breathing problems quickly worsen after taking Tudorza Pressair, contact 9-1-1 right away.1
These are not all the possible side effects of Tudorza Pressair. Talk to your doctor about what to expect or if you experience any changes that concern you during treatment with Tudorza Pressair.
Things to know about Tudorza Pressair
People who are allergic to milk proteins should not take Tudorza Pressair. It should also not be used with other drugs that contain anticholinergics.1
There is not enough data to know if Tudorza Pressair is safe to use when pregnant or breastfeeding. Before using this drug, tell your doctor if you are pregnant, plan to become pregnant, or breastfeeding.1